Who (What) Pays Toll for the Development of Herpetic Stromal Keratitis (HSK)

REFERENCES

• Akira S, Hemmi H. Recognition of pathogen-associated molecular patterns by TLR family. Immunol. Lett 2003; 85: 85–95
   PubMed Web of Science ®Google Scholar
• Araki-Sasaki K, Tanaka T, Ebisuno Y, Kanda H, Umemoto E, Hayashi K, Miyasaka M. Dynamic expression of chemokines and infiltration of inflammatory cells in the HSV-infected cornea and its associated tissue. Ocular Immunol. Inflamm 2006; 14: 257–266
   PubMed Web of Science ®Google Scholar
• Babu J S, Kanangat S, Rouse B T. T cell cytokine mRNA expression during the course of the immunopathologic ocular disease herpetic stromal keratitis. J Immunol. 1995; 154: 4822–4829
   PubMed Web of Science ®Google Scholar
• Babu J S, Thomas J, Kanangat S, Morrison I A, Knipe D M, Rouse B T. Viral replication is required for induction of ocular immunopathology by herpes simplex virus. J Virol 1996; 70: 101–107
   PubMed Web of Science ®Google Scholar
• Biswas P S, Rouse B T. Early events in HSV keratitis-setting the stage for a blinding disease. Microb. Infect 2005; 7: 799–810
   PubMed Web of Science ®Google Scholar
• Biswas P S, Benerjee K, Kinchington P R, Rouse B T. Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection. Exp. Eye Res 2006; 82: 46–54
   PubMed Web of Science ®Google Scholar
• Cesario T G, Poland J D, Wulff H, Chin T Y, Wenner H A. Six years experience with herpes simplex virus in a children's home. Am J Epidemiol 1969; 90: 416–422
   Google Scholar
• Daheshia M, Kanangat S, Rouse B T. Production of key molecules by ocular neutrophils early after herpetic infection of the cornea. Exp. Eye Res 1998a; 67: 619–624
   PubMed Web of Science ®Google Scholar
• Daheshia M, Kuklin N, Manickan E, Chun S, Rouse B T. Immune induction and modulation by topical ocular administration of plasmid DNA encoding antigens and cytokines. Vaccine 1998b; 16: 1103–1110
   PubMed Web of Science ®Google Scholar
• Darougar S, Wishart M S, Viswalingam N D. Epidemiological and clinical features of primary herpes simplex virus ocular infection. Brit. J Ophthalmol 1985; 69: 2–6
   PubMed Web of Science ®Google Scholar
• Deshpande S, Banerjee K, Biswas P S, Rouse B T. Herpetic eye disease: immunopatrhogenesis and therapeutic measure. Expert. Rev. Mol. Med 2004; 1–14
   Google Scholar
• Doymaz M Z, Rouse B T. Immunopathology of herpes simplex virus infections. Curr Top Microbiol Immunol 1992; 179: 121–136
   PubMedGoogle Scholar
• Duan R, Remeijer L, vanDun J M, Osterhaus AD ME, Verjans GM GM. Granulocyte macrophage colony-stimulating factor expression in human herpetic stromal keratitis: implications for the role of neutrophils in HSK. Invest. Ophthalmol. Vis. Sci. 2007; 48: 277–284
   PubMed Web of Science ®Google Scholar
• Easty D L, Shimeld C, Claoue C M, Menage M. Herpes simplex virus isolation in chronic stromal keratitis: human and laboratory studies. Curr. Eye Res 1987; 6: 69–74
   PubMed Web of Science ®Google Scholar
• Enquist L W, Husak P J, Banfield B W, Smith G A. Infection and spread of aqlphaherpesviruses in the nervous system. Adv. Virus Res 1998; 51: 237–347
   PubMedGoogle Scholar
• Fraser N W, Valyi-Nagy T. Viral, neuronal and immune factors which may influence herpes simplex virus (HSV) latency and reactivation. Microb. Pathog 1993; 15: 83–91
   Google Scholar
• Fukuda M, Deai T, Hibino T, Higaki S, Hayashi K, Shimomura Y. Quantitative analysis of herpes simplex virus genomes in tears from patients with herpetic keratits. Cornea 2003; 22(suppl 1)555–560
   Google Scholar
• Hayashi K, Hooper L C, Chin M S, Nagineni C N, Detrick B, Hooks J J. Herpes simplex virus 1 (HSV-1)DNA and immune complex (HSV-1 –human IgG) elicit vigorous interleukin 6 release from infected corneal cells via Toll-like receptors. J Gen Virol 2006; 87: 2161–2169
   PubMed Web of Science ®Google Scholar
• Herbst-Kralovetz M, Pyles R. Toll-like receptors, innate immunity and HSV pathogenesis. Herpes 2006; 13: 37–41
   Google Scholar
• Hui J, Zhang J, Kumar A, Zheng M, Atherton S S, Yu F SX. Herpes simplex virus 1 infection induces expression of proinflammatory cytokines, interferons and TLR 7 in human corneal epithelial cells. Immunology 2005; 117: 167–176
   Google Scholar
• Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol 2004; 5: 987–995
   PubMed Web of Science ®Google Scholar
• Jin X, Qin Q, Chen W, Qu J. Expression of Toll-like receptors in the healthy and herpes simplex virus-infected cornea. Cornea 2007; 26: 847–852
   PubMed Web of Science ®Google Scholar
• Kanangat S, Babu J S, Knipe D M, Rouse B T. HSV-1 mediated modulation of cytokine gene expression in a permissive cell line: selective upregulation of IL-6 gene expression. Virology 1996; 219: 295–300
   Google Scholar
• Kaufman H E, Azcuy A M, Varnell E D, Sloop G D, Thompson H W, Hill J M. HSV-1 DNA in tears and saliva of normal adults. . Invest. Ophthalmol. Vis. Sci 2005; 46: 241–247
   PubMed Web of Science ®Google Scholar
• Kaye S B, Baker E, Bonshek R, Maseruka H, Grinfeld E, Tullo A, Easty D, Hart C. Human herpes viruses in the cornea. Brit. J Ophthalmol 2000; 84: 563–571
   PubMedGoogle Scholar
• Kim B, Suvas S, Sarangi P P, Lee S, Reisfeld R A, Rouse B T. Vascular endothelial growth factor receptor 2- based DNA immunization delays development of herpetic stromal keratitis by antiangiogenic effects. J Immunol 2006; 177: 4122–4131
   Google Scholar
• Kimberlin D W. Neonatal herpes simplex infection. Clin. Microb. Rev 2004; 17: 1–13
   PubMed Web of Science ®Google Scholar
• Knotts F B, Cook M L, Stevens J G. Pathogenesis of herpetic encephalitis in mice after ophthalmic inoculation. J Infect Dis. 1974; 130: 16–24
   PubMed Web of Science ®Google Scholar
• Koelle D M, Reymond S N, Chen H, Kwok W W, McClurkan C, Gyaltsong T, Petersdorf E W, Rotkins W, Talley A R, Harrison D A. Tegment-specific, virus-reactive CD4T cells localize to the cornea in herpes simplex virus interstitial keratitis in humans. J Virol 2000; 74: 10930–10938
   PubMedGoogle Scholar
• Krug A, Luker G D, Barchet W, Leib D A, Akira S, Colonna M. Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood 2004; 103: 1433–1437
   PubMed Web of Science ®Google Scholar
• Kumaraguru U, Davis I, Rouse B T. Chemokines and ocular pathology caused by corneal infection with herpes simplex virus. J Neuro Virol 1999; 5: 42–47
   PubMed Web of Science ®Google Scholar
• Kumarugaru U, Rouse B T. The IL-12 response to herpes simplex virus is mainly a paracrine response of reactive inflammatory cells. J Leukoc Biol 2002; 71: 564–570
   Google Scholar
• Kurt-Jones E A, Chan M, Zhou S, Wang J U, Reed G, Bronson R, Arnold M M, Knipe D M, Finberg R W. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci USA 2004; 101: 1315–1320
   PubMed Web of Science ®Google Scholar
• Kwong A D, Kruper J A, Frenkel N. Herpes simplex virus virion host shutoff function. J Virol. 1988; 62: 912–921
   PubMed Web of Science ®Google Scholar
• Lee S, Zheng M, Kim B, Rouse B T. Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus. J Clin Invest 2002; 110: 1105–1111
   PubMed Web of Science ®Google Scholar
• Liesengang T J. Herpes simplex virus epidemiology and ocular importance. Cornea 2001; 20: 1–13
   Google Scholar
• Lund J, Sato A, Akira S, Medzhitov R, Iwasaki A. Toll-like receptor 9-mediated recognition of herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med 2003; 198: 513–520
   PubMed Web of Science ®Google Scholar
• Lundberg P, Welander P, Han X, Cantin E. Herpes simplex virus type 1 DNA is immunostimulatory in vitro and in vivo. J Virol 2003; 77: 11158–11169
   PubMedGoogle Scholar
• Macrtzdorf J, Osterhaus AD ME, Verjans GM GM. IL-17 expression in human herpetic stromal keratitis: modulatory effects on chemokine production by corneal fibroblasts. J Immunol 2002; 169: 5897–5903
   Google Scholar
• Maggs D J, Chang E, Nasisse M P, Mitchell W J. Persistence of herpes simplex virus type1 DNA in chronic conjunctival and eyelid lesions of mice. J Virol 1998; 72: 9166–9172
   Google Scholar
• Matsumoto M, Kikkawa S, Kohase M, Miyake K, Seya T. Establishment of monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochem Biophys Res Commun 2002; 293: 1364–1369
   PubMed Web of Science ®Google Scholar
• Mercadal C M, Bouley D M, DeStephano D, Rouse B T. Herpetic stromal keratitis in the reconstituted scid mouse model. J Virol 1993; 67: 3404–3408
   PubMedGoogle Scholar
• Metcalf J F, Hamilton D S, Reichert R W. Herpetic keratitis in athymic (nude) mice. Infect Immun 1979; 26: 1164–1171
   PubMed Web of Science ®Google Scholar
• Meyers R L, Chitjian P A. Immunology of herpesvirus infection: immunity to herpes simplex virus in eye infections. Surv. Ophthalmol 1976; 21: 194–204
   PubMedGoogle Scholar
• Meyers-Elliott R H, Chitjian P A, Dithiefs B A. Experimental herpesvirus keratits in the rabbit: topical versus intrastromal infection route. Ophthalmic Res 1983; 15: 240–256
   Google Scholar
• Meyers-Elliott R H, Petit T H, Maxwell W A. Viral antigens in the immune ring of Herpes simplex stromal keratitis. Arch Ophthalmol 1980; 98: 897–904
   PubMed Web of Science ®Google Scholar
• Miller J K, Laycock K A, Nash M M, Pepose J S. Corneal Langerhans cell dynamics after herpes simplex virus reactivation. Invest Ophthalmol Vis Sci 1993; 34: 2282–2290
   PubMed Web of Science ®Google Scholar
• Mitchell W, Gressens J P, Martin J R, DeSanto R. Herpes simplex virus type1 DNA persistence, progressive disease and transgenic immediate early gene promoter activity in chronic corneal infections in mice. J. Gen Virol 1994; 75: 1201–1210
   Google Scholar
• Pepose J S, Leib D A, Stuart M, Easty D. Herpes simplex virus disease: anterior segment of the eye. Ocular Infection and Immunity, J S Pepose, G N Holland, K R Wilhelmus. Mosby, St. Louis 1996; 905–932
   Google Scholar
• Shimeld C, Hill T J, Blyth B, Easty D. Improved model of recurrent herpetic eye disease in mice. Curr. Eye Res. 1989; 8: 1193–1205
   PubMed Web of Science ®Google Scholar
• Shimomura Y, Deai T, Fukuda M, Higaki S, Hoopre L C, Hayashi K. Corneal buttons obtained from patients with HSK harbor high copy number of the HSV genome. Cornea 2007; 26: 190–193
   PubMed Web of Science ®Google Scholar
• Streilein W J, Dana M R, Ksander B R. Immunity causing blindness: five different paths to herpes stromal keratits. Immunol Today 1997; 18: 443–449
   PubMedGoogle Scholar
• Su Y H, Yan X T, Oakes J E, Lausch R N. Protective antibody therapy is associated with reduced chemokine transcripts in herpes simplex virus type1 corneal infection. J Virol 1996; 70: 1277–1281
   PubMed Web of Science ®Google Scholar
• Suvas S, Azkur A K, Kim B S, Kumagaru U, Rouse B T. CD4+ CD25+ regulatory T cells control the severity of viral immunoimnflammatory lesions. J Immunol 2004; 172: 4123–4132
   PubMed Web of Science ®Google Scholar
• Taddeo B, Roizman B. The virion host shutoff (UL41) protein of herpes simplex virus 1 is an endoribonuclease with a substrate specificity similar to that of RNase A. J Virol. 2006; 80: 9341–9345
   Google Scholar
• Takada K, Kaisho T, Akira S. Toll-like receptors. Ann. Rev Immunol 2003; 21: 335–376
   Google Scholar
• Thomas J, Rouse B T. Immunopathogenesis of herpetic ocular disease. Immunol. Res. 1997; 16: 375–386
   PubMed Web of Science ®Google Scholar
• Thomas J, Kanangat S, Rouse B T. Herpes simplex virus replication-induced expression of chemokines and proinflammatory cytokines in the eye: implications in herpetic stromal keratitis. J Interferon Cytokine Res 1998; 18: 681–690
   PubMed Web of Science ®Google Scholar
• Tran M T, Dean D A, Lausch R N, Oakes J E. Members of herpes simplex type-1 infected human corneal epithelial cells are not permiabilized to macromolecules and therefore do not release IL-1 alpha. Virology 1998; 244: 74–78
   PubMed Web of Science ®Google Scholar
• Tullo A B, Schimeld C, Blyth W A, Hill T J, Easty D L. Spread of virus and distribution of latent infection following ocular herpes simplex in the non-immune and immune mouse. J Gen Virol 1982; 63: 95–101
   PubMed Web of Science ®Google Scholar
• Tullo A B, Shimeld C, Blyth W A, Hill T J, Easty D L. Ocular infection with herpes simplex virus in nonimmyne and immune mice. Arch. Ophtha lmol 1983; 101: 961–965
   PubMedGoogle Scholar
• Ueta M, Hamuro J, Kiyono H, Kinoshita S. Triggering of TLR-3 by poly I:C in human corneal epithelial cells to induce inflammatory cytokines. Biochem Biophys. Res. Comm. 2005; 331: 285–294
   PubMed Web of Science ®Google Scholar
• Verjans G M, Remeijer L, van Binnendijik R S, Cornelissen J G, Volker-Dieben H J, Baarsma S G, Osterhaus A D. Identification and characterization of herpes simplex virus-specific CD4 + T cells in corneas of herpetic stromal keratitis patients. J Infect. Dis 1998; 73: 484–488
   Google Scholar
• Wilhelmus K R, Gee L, Hauck W W, Kurinij N, Dawson C R, Jones D B, Barron B A, Kaufman H E, Sugar J, Hyndiuk R A. Herpetic Eye Study: a controlled trial of topical corticosteroids for herpes simplex stromal keratitis. Ophthalmology 1994; 101: 1883–1895
   PubMed Web of Science ®Google Scholar
• Youinou P, Colin I, Mottier D. Immunological analysis of the cornea in herpetic stromal keratitis. J Clin Lab Immunol 1985; 17: 105–106
   Google Scholar
• Youinou P, Colin J, Ferec C. Monoclonal antibody analysis of blood and cornea T lymphocyte subpopulations in herpes simplex keratitis. Graefes Arch. Clin. Exp. Ophthalmol 1986; 224: 131–133
   Google Scholar
• Whitley R J, Kimberlin D W. Herpoes simplex: Encephalitis children and adolescents. Semin. Ped. Inf. Dis 2005; 16: 17–23
   PubMedGoogle Scholar
• Zhang D, Zhang G, Hayden M S, Greenblatt M B, Bussey C, Flavell R A, Ghosh S. A Toll-like receptor that prevents infection by uropathogenic bacteria. Science 2004; 303: 1522–1526
   PubMed Web of Science ®Google Scholar
• Zheng M, Deshpande S, Lee S, Ferrara N, Rouse B T. Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis ofherpetic stromal keratitis. J Virol 2001a; 75: 9828–9835
   PubMed Web of Science ®Google Scholar
• Zheng M, Schwarz M A, Lee S, Kumaraguru U, Rouse B T. Control of stromal keratitis by inhibition of neovascularization. Am J Pathol 2001b; 159: 1021–1029
   PubMed Web of Science ®Google Scholar